These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6315581)

  • 1. Relationship of interferon-inducing particle phenotype to encephalomyocarditis virus-induced diabetes mellitus.
    Cohen SH; Bolton V; Jordan GW
    Infect Immun; 1983 Nov; 42(2):605-11. PubMed ID: 6315581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
    Kaptur PE; Thomas DC; Giron DJ
    Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss mice.
    Gould CL; Trombley ML; Bigley NJ; McMannama KG; Giron DJ
    Proc Soc Exp Biol Med; 1984 Apr; 175(4):449-53. PubMed ID: 6324221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.
    Yoon JW; McClintock PR; Onodera T; Notkins AL
    J Exp Med; 1980 Oct; 152(4):878-92. PubMed ID: 6252275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
    Jordan GW; Cohen SH
    Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two amino acids, Phe 16 and Ala 776, on the polyprotein are most likely to be responsible for the diabetogenicity of encephalomyocarditis virus.
    Bae YS; Eun HM; Pon RT; Giron D; Yoon JW
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():639-45. PubMed ID: 1690262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus.
    Cohen SH; Naviaux RK; vanden Brink KM; Jordan GW
    Virology; 1988 Oct; 166(2):603-7. PubMed ID: 2845665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus.
    Bae YS; Eun HM; Yoon JW
    Virology; 1989 May; 170(1):282-7. PubMed ID: 2541543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomic RNA of diabetogenic encephalomyocarditis virus: characterization and molecular cloning.
    Jordan GW; Cohen SH; Dandekar S; VandenBrink KM
    Virology; 1987 Jul; 159(1):120-5. PubMed ID: 3037773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in mice by interferon.
    Gould CL; McMannama KG; Bigley NJ; Giron DJ
    J Interferon Res; 1985; 5(1):33-7. PubMed ID: 3886808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
    Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
    Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus.
    Kaptur PE; Thomas DC; Giron DJ
    J Interferon Res; 1989 Dec; 9(6):671-8. PubMed ID: 2481700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification of diabetogenic viral gene.
    Bae YS; Eun HM; Yoon JW
    Diabetes; 1989 Mar; 38(3):316-20. PubMed ID: 2537245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of interferon in virus-induced diabetes.
    Yoon JW; Cha CY; Jordan GW
    J Infect Dis; 1983 Jan; 147(1):155-9. PubMed ID: 6337224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of diabetes and interferon induction by the diabetogenic strain of encephalomyocarditis virus through cell passage.
    Giron DJ; Patterson RR; Lyons SP
    J Interferon Res; 1982; 2(3):371-6. PubMed ID: 6290577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice.
    Kang Y; Yoon JW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1207-13. PubMed ID: 8389806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.
    Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK
    J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus.
    Eun HM; Bae YS; Yoon JW
    Virology; 1988 Apr; 163(2):369-73. PubMed ID: 2833013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of virus-induced diabetes mellitus by interferon is influenced by the host strain.
    Giron DJ; Cohen SJ; Lyons SP; Wharton CH; Cerutis DR
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):328-31. PubMed ID: 6306672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation.
    Yoon JW; Wong AK; Bae YS; Eun HM
    J Virol; 1988 Feb; 62(2):637-40. PubMed ID: 2826821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.